Geode Capital Management
DWTX

Geode Capital Management’s Dogwood Therapeutics DWTX Stock Holding History

Geode Capital Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
79,434
+62,655
+373% +$184K ﹤0.01% 3978
2025
Q4 		$69.8K Buy
16,779
+1,695
+11% +$9.98K ﹤0.01% 4172
2025
Q3 		$116K Buy
15,084
+2,261
+18% +$11.3K ﹤0.01% 4090
2025
Q2 		$61.9K Sell
12,823
-1,586
-11% -$7.67K ﹤0.01% 4168
2025
Q1 		$72.2K Buy
14,409
+3,476
+32% +$23.5K ﹤0.01% 4113
2024
Q4 		$27.1K Buy
10,933
+1,703
+18% +$5.64K ﹤0.01% 4343
2024
Q3 		$39.2K Buy
9,230
+2,251
+32% +$11.7K ﹤0.01% 4309
2024
Q2 		$37.5K Hold
6,979
– – ﹤0.01% 4337
2024
Q1 		$83.6K Hold
6,979
– – ﹤0.01% 4216
2023
Q4 		$100K Hold
6,979
– – ﹤0.01% 4186
2023
Q3 		$161K Buy
6,979
+1,088
+18% +$37.8K ﹤0.01% 4063
2023
Q2 		$203K Buy
5,891
+3,480
+144% +$99.3K ﹤0.01% 4035
2023
Q1 		$22.2K Hold
2,411
– – ﹤0.01% 4687
2022
Q4 		$14K Hold
2,411
– – ﹤0.01% 4810
2022
Q3 		$22K Buy
2,411
+1,116
+86% +$157K ﹤0.01% 4904
2022
Q2 		$136K Buy
1,295
+31
+2% +$3.24K ﹤0.01% 4455
2022
Q1 		$141K Buy
1,264
+361
+40% +$52.5K ﹤0.01% 4525
2021
Q4 		$115K Buy
903
+86
+11% +$10.9K ﹤0.01% 4685
2021
Q3 		$108K Buy
817
+77
+10% +$10.7K ﹤0.01% 4652
2021
Q2 		$116K Buy
+740
New +$105K ﹤0.01% 4518

Other funds holding DWTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management's DWTX Position: Q1 2026 in Review

Geode Capital Management increased its Dogwood Therapeutics (DWTX) stake by 373% in Q1 2026, buying an estimated $184K and bringing the position to 79,434 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #3978.

Geode Capital Management first reported a position in DWTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $203K in Q2 2023. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

  • Geode Capital Management held 79,434 shares of Dogwood Therapeutics worth $168K as of Q1 2026.
  • Geode Capital Management bought 62,655 Dogwood Therapeutics shares in Q1 2026, an estimated $184K.
  • Dogwood Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3978 holding.
  • Geode Capital Management first reported a position in Dogwood Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Dogwood Therapeutics position peaked at $203K in Q2 2023.
  • 13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.